Your cart is currently empty!
CiplaQCIL is a WHO-certified, cGMP-compliant pharmaceutical manufacturing company founded by 4 Ugandan Entrepreneurs and works with a world class technical partner, Cipla Limited of India. It was started 13 years ago with an entirely African manufacturing base.
The Company currently concentrates on the manufacture of WHO recommended treatments of three of Africa’s most terrible diseases, HIV/AIDS, malaria and hepatitis B, and will soon manufacture a cure for hepatitis C. CiplaQCIL is the only WHO cGMP-compliant pharmaceutical plant in Sub-Saharan Africa (SSA) that manufactures WHO-prequalified first-line treatments for both HIV/AIDS and malaria. The CiplaQCIL facility is now approved in 13 countries (compared to eight countries in March 2016), and ambition is to be registered in 19 SSA countries by December 2020.
-
HOW TO ANaLYSE
-
HOW TO BUY
-
HOW TO MONITOR
Address: | Plot 1-7, 1st Ring Road, Luzira Industrial Park P.O Box 34871, Kampala-Uganda |
Website: | |
Exchange: | Uganda Securities Exchange |
Cross-Listing: | None |
Founded: | 1997 |
Listed: | September 2018 |
Year End: | |
Reporting Currency | Uganda Shillings (UGX) |